Get notified of page updates

Prevention

Screening study to detect pancreatic cancer and precancer in people with either a strong family history of pancreatic cancer, or an inherited mutation associated with pancreatic cancer risk

Clinicaltrials.gov identifier:
NCT03250078

Study Contact Information:

Contact: Tammy Lo, APRN  by phone:  203-855-3551 or by email     
Contact: Pramila Krumholtz, RN by phone: 203-739-7997 by email 
Principal Investigator: Richard Frank, MD

PRINTER FRIENDLY PAGE

A Pancreatic Cancer Screening Study for High Risk Individuals

Prevention

Screening study to detect pancreatic cancer and precancer in people with either a strong family history of pancreatic cancer, or an inherited mutation associated with pancreatic cancer risk

Clinicaltrials.gov identifier:
NCT03250078

Study Contact Information:

Contact: Tammy Lo, APRN  by phone:  203-855-3551 or by email     
Contact: Pramila Krumholtz, RN by phone: 203-739-7997 by email 
Principal Investigator: Richard Frank, MD

PRINTER FRIENDLY PAGE
Overview
Who Can Join
Details
Contact
Locations
Glossary on
off

About the Study

The purpose of this study is to screen and detect pancreatic cancer and precancer in people with a strong family history of pancreatic cancer, or people with an and at least one first- or with pancreatic cancer. This includes people with (a mutation in , , , , or ) or an inherited mutation in , , , or .

Magnetic Resonance Imaging () will be used to screen for early pancreatic cancer. Participants will also be asked to donate a blood sample at specific intervals for the creation of a blood bank necessary for the development of a blood-based screening test for pancreatic cancer.    

This Study is Open To:

Men and women 50-80 years of age can participate if:

  • They have a strong family history of pancreatic cancer and 
    • at least two first-degree relatives with pancreatic cancer
    • at least three first-, second-, or third-degree relatives with pancreatic cancer with at least one pancreatic cancer in a first degree relative
  • They have (a mutation in , , , , or ) or an inherited mutation in , , , or and have at least one first- or with pancreatic cancer.

This Study is NOT Open To:

People are excluded if they:

  • Have a prior history of pancreatic cancer or have cancer
  • Have a cancer that required post-treatment chemotherapy within the past 5 years
  • Received chemotherapy within the past 6 months
  • Have hereditary pancreatitis
  • Are known to have a severe reaction to a gadolinium contrast or an exam

What the Study Involves

  • Participants will undergo a five-minute psychological survey and donation of a blood sample every 6 months for 3 years.
  • will be performed annually for 3 years (4 in total). Cost of will be covered by the study.
  • Any abnormalities on the will be reviewed by a multi-disciplinary tumor board and discussed with the study participant.

Study Contact Information:

Contact: Tammy Lo, APRN  by phone:  203-855-3551 or by email     
Contact: Pramila Krumholtz, RN by phone: 203-739-7997 by email 
Principal Investigator: Richard Frank, MD

Locations:

Connecticut

City: Norwalk RECRUITING
Facility: Nuvance Health
Contact Info:
Tammy.Lo@nuvancehealth.org 203-855-3551
Pramila.Krumholtz@nuvancehealth.org 203-739-7997
Richard Frank, MD